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1. Schistosoma haematobium: facts and figures 
 
2. The case of Guinea Bissau: school children 
 
3. Nutritional Status and Growth Indicators 
•Stunting 
•Wasting 
•Underweight 


Guinea Bissau   
Guinea-Bissau is one of the less 
developed countries in the world. 
 
The 1.6 million inhabitants live under 
extreme poverty, and water supply and 
sanitation cover less than half of the 
population. 
 
Although the WHO (2012) considers 
Guinea-Bissau to be a highly endemic 
country for schistosomiasis, to our 
knowledge this is the first study 
addressing the prevalence of this 
neglected tropical disease in this part of 
sub-Saharan Africa. 
 
 
 
90 schoolchildren aged 6 – 15 were targeted in 
this study.  
Growth Indicators 
Body weight and height were measured using 
a standardized method of anthropometric 
techniques. 
 
Height was measured to the nearest 0.1 
centimeters and weight was measured to the 
nearest 0.1 kg using portable digital scales. 
 
Body Mass Index (BMI) of each child was 
calculated as weight in kilograms divided by 
the square of height in meters (kg/m2). 
Nutritional Status 
Z scores of height-for-age (HAZ) and weight-
for-age (WAZ) were calculated using 
Nutritional Index Calculator (WHO, 1995). 
 
HAZ and WAZ values less than -2 were 
considered as stunting and wasting 
respectively as described by WHO (1995). 
 
BMI<15 kg/m2 was considered as underweight 
(WHO, 1995).  
12-year-old boy suffering from 
stunting and wasting due to 
schistosomiasis 
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Growth Indicators 
Sh -ve; 
n=72 
Sh +ve  
n=18 
p 
HAZ (mean±SD) 
WAZ (mean±SD) 
-0.58±1.11 
-0.80 ± 1.04 
-0.87±1.11 
-1.48±1.08 
n.s. 
p=0.01 
  
BMI (mean±SD) 14.6 2.16 13.9 2.67 n.s.   
Table 2. Overall growth indicators among children positive (Sh +ve) and negative (Sh –ve) for S. 
haematobium. 
n - number of individuals; HAZ – height-for-age z-score; WAZ – weight-
for-age z-score; BMI – Body mass index. 
Conclusions 
 
1. This survey provides for the first time data on  the prevalence of S. haematobium 
infection and undernutrition among schoolchildren across Guinea-Bissau.   
 
 
2. All Schistosoma species cause non-specific but disabling systemic morbidities 
including malnutrition and impaired childhood development, as a result of the effect 
of continued inflammation on normal growth, iron metabolism, physical fitness, and 
cognitive function.  
 
3. Efforts to provide nutritional interventions, deworming and vaccination to children  
are indicated. 
 
Future Perspectives 
 
1. Investigate schistosome catechol estrogen in urine of  Schistosoma infected children from 
Guinea Bissau.  
 
2. Evaluate impact of these catechol estrogens on growth impairment in these informative 
human cases. 
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